Novel insights into the comorbidity burden of severe asthma in Canada: Analysis of the Canadian Severe Asthma Registry
Alotaibi, N., Abercromby, S., Sadatsafavi, M., Côté, A., Lougheed, M. D., Philipenko, B., Couillard, S., Bhutani, M., Serajeddini, H., Abercromby, S., Friston, D., Scelo, G., Price, D., Bergeron, C.
Derivation and definitions of clinical study variables for multiple long term conditions in patients with chronic obstructive pulmonary disease: Protocol for a modified Delphi methods and consensus study on behalf of the International Cardiovascular and Respiratory Alliance
Joseph, T., Bhutani, M., Couper, A., Pullen, R., Nadarajah, R., Alves, L., Montero-Arias, M. F., Al-Lehebi, R., Berg, D., Hawkins, N. M., Hurst, J. R., Jenkins, C., Kaplan, A., Kocks, J. W., Kostikas, K., Lam, C. S., Lapperre, T. S., Rhee, C. K., Sattar, N., Stolz, D., Tse, G., Winders, T. A., Price, D., Gale, C. P.
Pragmatic and Observational Research, vol. 16, pp. 243—251
Economic burden of asthma multimorbidity in Singapore: Shadow costs of steroid use
Lim, L. H. M., Juang, Y. R., Chotirmall, S. H., Tan, K. B., Koh, M. S., Abisheganaden, J. A., Price, D. B., Tsai, M., Liew, M. F., Tiew, P. Y., Yii, A. C. A., Chen, W.
World Allergy Organization Journal, vol. 18, no. 12, 101146
Are adults with COPD in Australian primary care at a greater risk of cardiovascular events than adults without COPD?
Wiseman, R., Hew, M., Ko, B., Jenkins, C., Cochrane,, B., Thompson, P. J., Hancock, K. L., McDonald, V., Leong, P., Tyrer, F., Le Cheng, P., Le Lievre, C. E., Roussos, A., Dickens, A. P., Evans, A., Bushell, N., Botini, F., Carter, V., Catanzariti, A., Bosnic-Anticevich, S. Z., Novic, D., Perret, J., Ranasinghe, K., Sharma, A., Stewart, D., Le, T., Price, D.
Clinical profile of severe asthma (SA) patients Mexican vs Global data and evolution once in the international severe asthma registry (ISAR)
Larenas-Linnemann, D., Cerda-Reyes, S., García-Ramírez, U., Castillón-Benavides, N., Contreras Contreras, E. A., Barboa, L., Aguilar-Hinojosa, N., Rivera-Alvarado, K., Ochoa-García, I. V., Azuara-Trujillo, H., Navarrete-Rodríguez, E., Jiménez-Carrillo, C., Mendoza Reyna, L. D., Friston, D., Scelo, G., Price, D.
Extrafine beclometasone/formoterol is non-inferior to budesonide/formoterol as maintenance and reliever therapy (MART) for adult asthma patients and reduces the total carbon footprint of all inhaler-related greenhouse gas (GHG) emissions
Jenkins, C., Ramakrishnan, S., Farah, C., Crooks, M., Tyrer, F., Pathak, S., Roussos, A., Ariti, C., Townend, J., Ravi, R., Tham, M., Carter, V., Bardin, P. G., Wark, P. A., Price, D.
Long-term exacerbation trends before/after initiating triple therapy for uncontrolled asthma
Roche, N., Brusselle, G., Gayle, A., Di Palma, L., Piraino, A., Scaffidi-Argentina, U., Grainge, C., Singh, D., Carter, V., Shi Kai Chan, J., Henley, W., Neil, D., Skinner, D., Streeter, A., Price, D.
A 21-practice evaluation of an asthma and COPD quality improvement program
Blakey, J. D., Bosnic-Anticevich, S., Cvetkovski, B., Hancock, K., Le Cheng, P., Tyrer, F., Townend, J., Hew, M., Del Fante, P., Ranasinghe, K., Thompson, P., Smith, P., Soumakiyan, M., Stewart, D., Sharma, A., Willet, B., Abutalieva, K., Le Lievre, C. E., Roussos, A., Accalai, P., Botini, F., Bushell, N., Carter, V., Le, T., Price, D., OPCA Improving Asthma outcomes in Australia Research Group
Journal of Asthma and Allergy, vol. 2025, no. 18, pp. 1599—1613
Validity of using prescription medications to classify disease: a retrospective observational study using routinely collected electronic health records from the UK
Schnier, C., Busby, J., Sheikh, A., Quint, J. K., Price, D., Heaney, L. G.
Pragmatic and Observational Research
Contributions to Journals: Articles
Corticosteroid burden and potentially related comorbidities in severe asthma: insights from East and Southeast Asia
Price, D., Koh, M. S., Scelo, G., Ravindra, J. S., Tran, T. N., Iwanaga, T., Rhee, C. K., Perng, D. W., Hsiao, Y. H., Friston, D.
29th Congress of the Asian Pacific Society of Respirology, PS02-0917
Changes in use and utilisation patterns of drugs with reported shortages between 2010 and 2024 in Europe and North America: a network cohort study
Pineda-Moncusí, M., Rekkas, A., Martínez Pérez, ?., Leis, A., Lopez Gomez, C., Fey, E., Bruninx, E., Maljković, F., Sánchez-Sáez, F., Rodeiro-Boliart, J., Zsuzsa Kiss, L., Franz, M., Mayer, M., Eleangovan, N., Pulido, P. P., Natsiavas, P., Şen, S., Cooper, S., Reisberg, S., Manlik, K., Price, D. B., Moscetti, L., Merkelbach, M., Tadrous, M., Rappoport, N., Claire, R., Garcia-Torrens, S., Prieto-Alhambra, D., Rijnbeek, P. R., Burkard, T., López Gómez, C., Rodeiro, J., Kiss, L. Z., Pericàs Pulido, P., del Pino, B., Prats Uribe, A., Üresin, A. Y., Danilović Bastić, A., Rodrigues, A. M., Afonso, ?., Palomar-Cros, A., Verbiest, A., Delmestri, A., Erdoğan, B., Dinkel-Keuthage, C., Torre, C. O., de Beukelaar, C., Eteve-Pitsaer, C., Gonçalves, C. F., de Palma, C., Drug Shortages EHDEN Study Group
The Lancet Public Health, vol. 10, no. 10, pp. e835-e847
Clinical effectiveness of anti-inflammatory reliever therapies (AIR) for asthma control: a non-inferiority study
Crooks, M., Tyrer, F., Malone, R., Jackson, A., Beasley, R., Carter, V., Eleangovan, N., Henley, W., Pavord, I. D., Wark, P. A., Lipworth, B., Price, D.
Measuring the Impact of the CONQUEST COPD Quality Improvement Programme in UK Primary Care
Vijaykumar, E., Gatenby, J., Freeman, D., Evans, A., Dickens, A. P., Couper, A., Stolz, D., Alves, L., Ariti, C., Carter, V., Chen, R., Eleangovan, N., Gale, C. P., Halpin, D. M. G., Henley, W., Hickman, K., Hurst, J. R., Miravitlles, M., Morries, T., Muellerova, H., Natman, J., Pullen, R., Quint, J., Singh, M., Singh, D., Varghese, D., Winders, T. A., Price, D.
Expert Perspectives on Next Generation Health Guidelines: How to Integrate RWE in EBM
del Giacco, S., Canonica, G. W., Agache, I., Price, D., Roche, N., Schünemann, H. J., Allan, K., Ansotegui, I. J., Barbaglia, S., Bernstein, J. A., Bonini, M., Bosnic-Anticevich, S., Bousquet, J., Carter, V., Chong-Neto, H. J., Fletton, K., González-Díaz, S., Gupta, V. A., Hubbard, R., Iaccarino, J., Eguiluz-Gracia, I., Jacomelli, C., Kocks, J., Krishnan, J. A., Mahler, V., Morais-Almeida, M., Moreles, D., Muti, P., Palkonen, S., Papadopoulos, N. G., Pawankar, R., Reeb, C., Reddel, H. K., Rojo, I., Ryan, D., Sodhi, L., Torres, M., Winders, T. A., Wilson, K. C.
Pragmatic and Observational Research, vol. 16, pp. 169-177
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approach
Wang, E., Henley, W., Larenas-Linnemann, D., Bulathsinhala, L., Tran, T. N., Wechsler, M. E., Aaron, S. D., Al-Ahmad, M., Al-Lehebi, R., Altraja, A., Barker, P., Beastall, A., Belevskiy, A. S., Bergeron, C., Bjermer, L., Björnsdóttir, U. S., Bosnic-Anticevich, S. Z., Bourdin, A., Brusselle, G. G., Busby, J., Canonica, G. W., Carter, V., Chapman, K. R., Chapman, N., Christoff, G. C., Cosio, B. G., Costello, R. W., Fingleton, J., ioa Fonseca, J. A., Gaga, M., Gibson, P. G., Hansen, S., Heaney, L. G., Heffler, E., Hew, M., Horiguchi, T., Hoyte, F., Hubbard, R. B., Iwanaga, T., Jackson, D. J., Katial, R., Koh, M. S., Kostikas, K., Kuna, P., Lehmann, S., Lehtimäki, L., Louis, R., Lúdvíksdóttir, D., Lugogo, N., Mahboub, B., Martin, N., Máspero, J., Menzies-Gow, A. N., Mohan, A., Murray, R. B., Nagano, T., Papadopoulos, N. G., Papaioannou, A. I., Patel, P. H., Perez-de-Llano, L., Perng, D., Peters, M. J., Pfeffer, P. E., Pitrez, P. M., Pleasants, R. A., Popov, T. A., Porsbjerg, C. M., Puggioni, F., Quinton, A., Rhee, C. K., Sadatsafavi, M., Salvi, S., Scioscia, G., Sheu, C., Sirena, C., Taillé, C., Taube, C., Torres-Duque, C. A., Tsai, M., Tunsäter, A., Ulrik, C. S., Price, D. B.
The Journal of Allergy and Clinical Immunology: In Practice
Burden of oral corticosteroid use in severe asthma: challenges and opportunities
Walter Canonica, G., Porsbjerg, C., Price, D., Wechsler, M. E., Heaney, L. G., Hanania, N. A., Gall, R., Pandit-Abid, N., Jacob-Nara, J. A., Sacks, H. J.
Impact of biologics initiation on oral corticosteroid use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: a pooled analysis of real-world data
Chen, W., Tran, T. N., Townend, J., Christoff, G. C., Tsai, M., Altraja, A., Cochrane, B., Cosio, B. G., Sivori, M., Murray, R. B., Makris, M. P., Scelo, G., Bulathsinhala, L., Ardusso, L. R., Franchi, M. E., Máspero, J., Saldarini, F., Stok, A. M., Tomaszuk, A. G., Yañez, A., Emmanuel, B., Emmas, C., Kostikas, K., Menzies-Gow, A. N., Stjepanovic, N., Bosnic-Anticevich, S. Z., Denton, E., Gibson, P. G., Hew, M., Jenkins, C., Middleton, P. G., Peters, M. J., Upham, J. W., Brusselle, G. G., Louis, R., Schleich, F., Pitrez, P. M., Popov, T. A., Bergeron, C., Bhutani, M., Chapman, K. R., Côté, A., Couillard, S., Dorscheid, D. R., Lougheed, M. D., Sadatsafavi, M., Celis- Preciado, C. A., Jiménez-Maldonado, L., Rodríguez- Cáceres, B., Cano Rosales, D. J., Solarte, I., Torres-Duque, C. A., Hansen, S., Porsbjerg, C. M., Ulrik, C. S., Bourdin, A., Bakakos, P., Exarchos, K. P., Gogali, A., Ladias, A. A., Papadopoulos, N. G., Papaioannou, A. I., Costello, R. W., Cushen, B., Mitchell, P. D., Canonica, G. W., Heffler, E., Puggioni, F., Iwanaga, T., Nagano, T., Tohda, Y., Al-Ahmad, M. S., Linnemann, D. L., Aarli, B. B., Lehmann, S., Kuna, P., Ferreira, J. A., Fonseca, J. A., Loureiro, C. C., Al-Lehebi, R., Bulkhi, A. A., Juang, Y. R., Koh, M. S., Liu, A., Rhee, C. K., Perez-de-Llano, L., Fu, P., Perng, D., Sheu, C., Wang, H., Mahboub, B., Salameh, L., Busby, J., Heaney, L. G., Jackson, D. J., Patel, P. H., Pfeffer, P. E., Hoyte, F., Katial, R. K., Lugogo, N., Pleasants, R. A., Wang, E., Wechsler, M. E., Beastall, A., Carter, V., Eleangovan, N., Fletton, K., Price, D. B.
The Journal of Allergy and Clinical Immunology: In Practice, vol. 13, no. 8, pp. 2033-2048
Prediction pathway for severe asthma exacerbations: a Bayesian Network analysis
Yadav, C. P., Chakraborty, A., Price, D., Huey Mien, L. L., Juang, Y. R., Beasley, R., Sadatsafavi, M., Janson, C., Koh, M. S., Wang, E., Wechsler, M. E., Jackson, D. J., Busby, J., Heaney, L. G., Pfeffer, P. E., Mahboub, B., Perng, D. W., Cosio, B. G., Perez de Llano, L., Al-Lehebi, R., Larenas-Linnemann, D., Al-Ahmad, M. S., Rhee, C. K., Iwanaga, T., Heffler, E., Canonica, G. W., Costello, R. W., Papadopoulos, N. G., Papaioannou, A. I., Porsbjerg, C. M., Torres-Duque, C. A., Christoff, G. C., Popov, T. A., Hew, M., Peters, M. J., Gibson, P. G., Máspero, J. F., Bergeron, C., Cerda, S., Contreras, E. A., Chen, W.
Effect of budesonide/glycopyrronium/formoterol fumarate dihydrate on cardiopulmonary outcomes in COPD: rationale and design of the THARROS trial
Martinez, F. J., Hurst, J. R., Han, M. K., Price, D., Zheng, J., Berg, D., Pszczol, M., Bafadhel, M., Lam, C. S., Fredriksson, M., Cowie, M. R., Arya, N., Bowen, K., Mushunje, A., Patel, M.
Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR)
Schleich, F., Larenas-Linnemann, D., Altraja, A., Pérez de Llano, L., Kostikas, K., Sadatsafavi, M., Bourdin, A., Pleasants, R. A., Hew, M., Chen, W., Jiménez-Maldonado, L., Couillard, S., Suppli Ulrik, C., Bulkhi, A. A., Tsai, M., Christoff, G. C., Papadopoulos, N. G., Pfeffer, P. E., Ryan, D., Bergeron, C., Al-Ahmad, M. S., Dorscheid, D. R., Wang, E., Blakey, J. D., Cochrane, B., Peters, M. J., Popov, T. A., Torres-Duque, C. A., Hansen, S., Puggioni, F., Fletton, K., Salameh, L., Middleton, P. G., Márcio Pitrez, P., Kook Rhee, C., Denton, E., Chapman, K. R., Lehtimäki, L., Murray, R. B., Sheu, C., Jackson, D. J., Al-Lehebi, R., Siyue Koh, M., Mahboub, B., Ardusso, L. R., Gogali, A., Canonica, G. W., Kuna, P., Townend, J., Cosio, B. G., Patel, P. H., Goh, Y. Y. C., Csoma, Z., Upham, J. W., Fonseca, J. A., Gibson, P. G., Jenkins, C., Brusselle, G., Chèvremont, A., Côté, A., Celis-Preciado, C. A., Solarte, I., Porsbjerg, C. M., Sverrild, A., Kauppi, P., Loukides, S., Makris, M. P., Papaioannou, A. I., Heffler, E., Chan, J. S. K., Joo, H., Heaney, L. G., Cheng, W., Lugogo, N., Wechsler, M. E., Loureiro, C. C., Rodríguez-Cáceres, B., Nagano, T., Wang, Z., Wang, H., Máspero, J., Saldarini, F., Stok, A. M., Yañez, A., Bardin, P. G., Bosnic-Anticevich, S. Z., Navaratnam, V., Bhutani, M., Lougheed, M. D., Melenka, L., Bakakos, P., Exarchos, K. P., Ladias, A. A., Lúdvíksdóttir, D., Iwanaga, T., Contreras Contreras, E. A., Lehmann, S., Ferreira, J. A., Gall, R., Fu, P., Perng, D. W., Hoyte, F., Katial, R., Björnsdóttir, U., Taillé, C., Taube, C., Cushen, B., Bulathsinhala, L., Bjermer, L., Price, D. B., the ISAR STAR Working Group
World Allergy Organization Journal, vol. 18, no. 7, 101066
Dupilumab Improves Health-Related Quality Of Life And Asthma Control In Patients With And Without Coexisting Type 2 Conditions: Results From The RAPID Study
Mosnaim, G. S., Price, D., Côté, A., Plaza, V., Xia, C., Awad, H., Kwah, J.
Outcomes In Patients With Asthma and Coexisting Allergic Rhinitis Who Started Dupilumab Treatment In Real-World Clinical Practice: A RAPID Registry Study
Côté, A., Muñoz, X., Price, D., Mosnaim, G., Xia, C., Awad, H., Kwah, J. H.
Practical Strategies for Achieving System Change in the US: Lessons and Insights from the CONQUEST Quality Improvement Program
Evans, A., VanWyk, J., Kerr, M., Couper, A., Pace, W. D., Tarabichi, Y., Pullen, R., Pollack, M., Drummond, M. B., Ohar, J. A., Meldrum, C., Han, M. K., Kaplan, A., Winders, T. A., Wisnivesky, J., Make, B., Federman, A., Carter, V., Lang, K., Mapel, D., Hanania, N. A., Stolz, D., Martinez, F. J., Price, D.
Primary Health Care Research and Development, vol. 26, e50
Pragmatic Evaluation of an Improvement Program for People Living With Modifiable High-Risk COPD Versus Usual Care: Protocols for the Cluster Randomized PREVAIL Trial
Hickman, K., Tarabichi, Y., Dickens, A. P., Pullen, R., Kerr, M., Couper, A., Evans, A., Gatenby, J., Alves, L., Ariti, C., Bafadhel, M., Carter, V., Chalmers, J., Chen, R., Devereux, G., Drummond, M. B., Gibson, J. M., Halpin, D. M. G., Han, M., Hanania, N. A., Hurst, J. R., Kaplan, A., Kostikas, K., Make, B., Mapel, D., Marshall, J., Martinez, F., Meldrum, C., van Melle, M., Miravitlles, M., Morris, T., Mullerova, H., Murray, R., Muro, S., Nordon, C., Ohar, J., Pace, W., Pollack, M., Quint, J. K., Sharma, A., Singh, D., Singh, M., Trudo, F., Williams, D., Wilkinson, T., Winders, T., Price, D.
Prevention of cardiovascular and other systemic adverse outcomes in patients with asthma treated with biologics
Sadatsafavi, M., Tran, T. N., Scelo, G., Tsai, M., Busby, J., Emmanuel, B., Heaney, L. G., Jenkins, C., Hoyte, F. L., Canonica, G. W., Katial, R., Heffler, E., Wang, E., Puggioni, F., Wechsler, M. E., Ardusso, L. R. F., Maspero, J. F., Sivori, M., Emmas, C., Menzies-Gow, A., Stjepanovic, N., Bosnic-Anticevich, S. Z., Cochrane,, B., Denton, E., Gibson, P. G., Hew, M., Middleton, P. G., Peters, M. J., Brusselle, G., Louis, R., Schleich, F., Christoff, G. C., Popov, T. A., Bergeron, C., Bhutani, M., Chapman, K. R., Côté, A., Couillard, S., Dorscheid, D. R., Jiménez-Maldonado, L., Solarte, I., Torres-Duque, C. A., Hansen, S., Porsbjerg, C. M., Suppli Ulrik, C., Altraja, A., Bourdin, A., Exarchos, K. P., Gogali, A., Kostikas, K., Makris, M. P., Papaioannou, A. I., Mitchell, P., Iwanaga, T., Nagano, T., Tohda, Y., Al-Ahmad, M. S., Larenas-Linnemann, D., Bøgvald Aarli, B., Kuna, P., Loureiro, C. C., Al-Lehebi, R., Bulkhi, A. A., Chen, W., Juang, Y. R., Koh, M. S., Liu, A., Rhee, C. K., Cosio, B. G., Perez de Llano, L., Perng, D. W., Sheu, C., Wang, H., Mahboub, B., Salameh, L., Jackson, D. J., Patel, P. H., Pfeffer, P. E., Lugogo, N., Pleasants, R. A., Beastall, A., Bulathsinhala, L., Carter, V., Eleangovan, N., Fletton, K., Townend, J., Murray, R. B., Price, D., ISAR SOLAR II Working Group
American Journal of Respiratory and Critical Care Medicine
Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCT
Devereux, G., Cotton, S., Nath, M., McMeekin, N., Campbell, K., Chaudhuri, R., Choudhury, G., De Soyza, A., Fielding, S., Gompertz, S., Haughney, J., Lee, A., MacLennan, G., Morice, A., Norrie, J., Price, D., Short, P., Vestbo, J., Walker, P., Wedzicha, J., Wilson, A., Wu, O., Lipworth, B.
Health Technology Assessment, vol. 29, no. 17, pp. i-xvi, 1-97
Impact of Biologic Initiation on New-Onset of Corticosteroid-Related Adverse Effects in Patients with Severe Asthma
Price, D., Emmanuel, B., Scelo, G., Altraja, A., Cochrane,, B., Chen, W., Koh, M. S., Solarte Rodriguez, I., Tsai, M., Suppli Ulrik, C., Bergeron, C., Christoff, G. C., Gogali, A., Hansen, S., Hew, M., Katial, R., Perez de Llano, L., Puggioni, F., Bulkhi, A. A., Côté, A., Emmas, C., Heaney, L. G., Jiménez-Maldonado, L., Mitchell, P., Papaioannou, A. I., Schleich, F., Sheu, C., Maspero, J. F., Gibson, P. G., Torres-Duque, C. A., Porsbjerg, C. M., Bourdin, A., Canonica, G. W., Heffler, E., Iwanaga, T., Larenas-Linnemann, D., Kuna, P., Al-Lehebi, R., Rhee, C. K., Cosio, B. G., Perng, D. W., Mahboub, B., Busby, J., Jackson, D. J., Patel, P. H., Pfeffer, P. E., Fletton, K., Murray, R. B., Townend, J., Tran, T. N., ISAR SOLAR II Working Group
American Thoracic Society Conference 2025, pp. A5552
Offering Digital Adherence Support Improves Clinical Outcomes for High-risk Chronic Obstructive Pulmonary Disease (COPD) Patients with Poor Adherence to Inhaled Therapy
Price, D., Dickens, A. P., Henley, W., Skinner, D., Pinnock, H., van Boven, J. F., Roche, N., Kostikas, K., Beeh, K. M., Usmani, O., Clark, A., Chalmers, J. D., Kaplan, A., Carter, V., Smith, U., Burnett-Kirton, Z., White, S. M., Davis, S. R., Hannan, N., Igwe, F., Mastoridis, P., Mezzi, K., Pfister, P., Halpin, D. M.
Patterns of care in the management of high-risk COPD in Australia (2015–2019): observational study for the CONQUEST quality improvement program
Jenkins, C., Dickens, A. P., Evans, A., Le Cheng, P., Heraud, F., Hancock, K., Sharma, A., Cochrane,, B., Roussos, A., Le Lievre, C. E., Blakey, J. D., Bosnic-Anticevich, S., Carter, V., Catanzariti, A., Ghisla, C., Hew, M., Ko, B., Le, T., Leong, P., McDonald, V., Lau, C. M., Perret, J., Pullen, R., Ranasinghe, K., Soriano, J. B., Stewart, D., van Melle, M., Wiseman, R., Price, D.
The Lancet Regional Health - Western Pacific, vol. 58, 101555
The BETRI study: preliminary information on characteristics of patients with asthma or asthma-COPD overlap treated with Medium-Strength Inhaled Corticosteroid / Long-Acting Beta-Agonists (ICS/LABA) and switching to High-Strength ICS/LABA or Medium-Strength Beclomethasone /Formoterol /Glycopyrronium (BDP/FF/G)
Piraino, A., Brusselle, G., Grainge, C., Roche, N., Gayle, A., Carter, V., Price, D., Di Palma, L., Singh, D.
CodeX effectively identifies high-risk patients with asthma or COPD in Dutch primary care, supporting guideline-driven treatment: Therapeutic Advances in Respiratory Disease
International Severe Asthma Registry (ISAR): 2017-2024 Status and Progress Update
Larenas-Linnemann, D., Rhee, C. K., Altraja, A., Busby, J., Tran, T. N., Wang, E., Popov, T. A., Mitchell, P. D., Pfeffer, P. E., Pleasants, R. A., Katial, R., Koh, M. S., Bourdin, A., Schleich, F., Máspero, J., Hew, M., Peters, M. J., Jackson, D. J., Christoff, G. C., Perez-de-Llano, L., Cherrez-Ojeda, I., Fonseca, J. A., Costello, R. W., Torres-Duque, C. A., Kuna, P., Menzies-Gow, A. N., Stjepanovic, N., Gibson, P. G., Pitrez, P. M., Bergeron, C., Porsbjerg, C. M., Taillé, C., Taube, C., Papadopoulos, N. G., Papaioannou, A. I., Salvi, S., Canonica, G. W., Heffler, E., Iwanaga, T., Al-Ahmad, M. S., Lehmann, S., Al-Lehebi, R., Cosio, B. G., Perng, D., Mahboub, B., Heaney, L. G., Patel, P. H., Lugogo, N., Wechsler, M. E., Bulathsinhala, L., Carter, V., Fletton, K., Neil, D. L., Scelo, G., Price, D. B.
Tuberculosis & Respiratory Diseases, vol. 88, no. 2, pp. 193-215
Characteristics of Asthma Patients Escalating from msICS/LABA to hsICS/LABA or msBDP/FF/G
Piraino, A., Roche, N., Gayle, A., Brusselle, G., Chan, J. S. K., Carter, V., Grainge, C., Henley, W., Rossetti, L. D. M., Singh, D., Skinner, D., Streeter, A., Roussos, A., Tham, M., Price, D.
TSANZSRS 2025
Contributions to Conferences: Abstracts
Predicting risk of morbidities associated with oral corticosteroid prescription for asthma
Stanley, B., Chapaneri, J., Khezrian, M., Maslova, E., Patel, S., Gurnell, M., Canonica, G. W., Reddel, H. K., Heaney, L. G., Bourdin, A., Neilly, D., Carter, V., Price, D.
Pragmatic and Observational Research, vol. 2025, no. 16, pp. 95-109
Adopting Australian Asthma Handbook's Option A could reduce carbon footprint
Smith, P., Bosnic-Anticevich, S., Botini,, F., Bushell, N., Carter, V., Catanzariti, A., Le Cheng, P., Cochrane,, B., Crooks, W., Hancock, K., Hew, M., Le Lievre, C. E., Le, T., Ranasinghe, K., Rigby, D., Roussos, A., Stewart, D., Thompson, P., Upham, J. W., Wiseman, R., Price, D.
TSANZSRS 2025
Contributions to Conferences: Abstracts
High-risk COPD patient management opportunities: Australia, US and UK comparisons
Cochrane,, B., Couper, A., Pullen, R., Dickens, A. P., Evans, A., Le Cheng, P., Perret, J., Bosnic-Anticevich, S., Kerr, M., Botini, F., Carter, V., Catanzariti, A., Hancock, K., Hew, M., Jenkins, C., Ko, B., Le, T., Leong, P., Le Lievre, C. E., McDonald, V., Murray, R., Roussos, A., Smith, P., Stewart, D., Ranasinghe, K., Price, D.
TSANZSRS 2025
Contributions to Conferences: Abstracts
Real-World Biologic Use Patterns in Severe Asthma, 2015–2021: the CLEAR Study
Tran, T. N., Chen, S., Emmanuel, B., Altraja, A., Bourdin, A., Sheu, C., Tsai, M., Hoyte, F. C. L., Quinton, A., Cook, B., Bulathsinhala, L., Henley, W., Goh, C. Y., Liu, Y., Ariti, C., Carter, V., Price, D., CLEAR Study Working Group
Pragmatic and Observational Research, vol. 16, pp. 51-66
Identification and management of cardiopulmonary risk in patients with COPD: a multidisciplinary consensus and modified Delphi study
Gale, C. P., Hurst, J. R., Hawkins, N. M., Bourbeau, J., Han, M. K., Lam, C. S. P., Marciniuk, D. D., Price, D., Stolz, D., Gluckman, T., Zieroth, S., Nadarajah, R., Young, R. P., Singh, D., Martinez, F. J., Berg, D. D., Bhutani, M., the Global Working Group on Cardiopulmonary Risk
European Journal of Preventive Cardiology, pp. zwaf119
Incidence and survival of Interstitial Lung Diseases in the UK in 2010-2019
Gonnelli, F., Eleangovan, N., Smith, U., Heatley, H., Navarantam, V., Corte, T. J., Price, D., Carter, V., Bonifazi, M., Fermoyle, C. C., Hubbard, R. B.
Using routine primary care data in research: (in)efficient case studies and perspectives from the Asthma UK Centre for Applied Research
Tibble, H., Alyami, R., Bush, A., Cunningham, S., Julious, S. A., Price, D., Quint, J. K., Turner, S., Wang, K., Wilson, A., Davies, G. A., Mukherjee, M., Chan, A. H. Y., Varghese, D., Jackson, T., Morgan, N., Daines, L., Pinnock, H.
BMJ Health Care Informatics, vol. 32, no. 1, e10113
